HERON THERAPEUTICS, INC. /DE/ Basic Shares Outstanding (Weighted Average)
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Basic Shares Outstanding (Weighted Average) of 190.34 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 190.34M shares, a 23.58% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 189.65M shares, a 23.56% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 188.26M shares, a 22.92% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 170.35M shares, a 11.46% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic for fiscal 2025 was 166.71M shares, a 9.35% increase from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic for fiscal 2024 was 152.45M shares, a 10.36% increase from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic for fiscal 2023 was 138.13M shares, a 26.87% increase from fiscal 2022.
- HERON THERAPEUTICS, INC. /DE/ weighted average number of shares outstanding, basic for fiscal 2022 was 108.88M shares, a 110466.56% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 190.34M shares 10-Q · filed 2026-08-10 | 189.99M shares 10-Q · filed 2026-08-10 | 189.41M shares derived: average of 3 quarters · filed 2026-08-10 | 184.65M shares derived: average of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | 189.65M shares 10-Q · filed 2026-05-11 | 188.95M shares derived: average of 2 quarters · filed 2026-05-11 | 182.75M shares derived: average of 3 quarters · filed 2026-05-11 | 175.57M shares derived: average of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | 188.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 179.30M shares derived: average of 2 quarters · filed 2026-02-26 | 170.87M shares derived: average of 3 quarters · filed 2026-08-10 | 166.71M shares 10-K · filed 2026-02-26 | |
| 2025-09-30 | 170.35M shares 10-Q · filed 2025-11-04 | 162.18M shares derived: average of 2 quarters · filed 2026-08-10 | 159.52M shares 10-Q · filed 2025-11-04 | 157.75M shares derived: average of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | 154.02M shares 10-Q · filed 2026-08-10 | 153.80M shares 10-Q · filed 2026-08-10 | 153.56M shares derived: average of 3 quarters · filed 2026-08-10 | 153.37M shares derived: average of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | 153.49M shares 10-Q · filed 2026-05-11 | 153.32M shares derived: average of 2 quarters · filed 2026-05-11 | 153.16M shares derived: average of 3 quarters · filed 2026-05-11 | 152.95M shares derived: average of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | 153.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 152.99M shares derived: average of 2 quarters · filed 2026-02-26 | 152.76M shares derived: average of 3 quarters · filed 2026-02-26 | 152.45M shares 10-K · filed 2026-02-26 | |
| 2024-09-30 | 152.83M shares 10-Q · filed 2025-11-04 | 152.57M shares derived: average of 2 quarters · filed 2025-11-04 | 152.21M shares 10-Q · filed 2025-11-04 | 151.91M shares derived: average of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | 152.31M shares 10-Q · filed 2025-08-08 | 151.90M shares 10-Q · filed 2025-08-08 | 151.60M shares derived: average of 3 quarters · filed 2026-02-26 | 149.95M shares derived: average of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | 151.20M shares 10-Q · filed 2025-05-06 | 151.25M shares derived: average of 2 quarters · filed 2026-02-26 | 149.16M shares derived: average of 3 quarters · filed 2026-02-26 | 141.80M shares derived: average of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | 151.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 148.14M shares derived: average of 2 quarters · filed 2026-02-26 | 138.67M shares derived: average of 3 quarters · filed 2026-02-26 | 138.13M shares 10-K · filed 2026-02-26 | |
| 2023-09-30 | 144.99M shares 10-Q · filed 2024-11-12 | 132.35M shares derived: average of 2 quarters · filed 2024-11-12 | 133.75M shares 10-Q · filed 2024-11-12 | 125.77M shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | 119.72M shares 10-Q · filed 2024-08-06 | 119.48M shares 10-Q · filed 2024-08-06 | 119.37M shares derived: average of 3 quarters · filed 2025-02-27 | 117.46M shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | 119.25M shares 10-Q · filed 2024-05-07 | 119.19M shares derived: average of 2 quarters · filed 2025-02-27 | 116.71M shares derived: average of 3 quarters · filed 2025-02-27 | 113.13M shares derived: average of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | 119.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 115.44M shares derived: average of 2 quarters · filed 2025-02-27 | 111.09M shares derived: average of 3 quarters · filed 2025-02-27 | 108.88M shares 10-K · filed 2025-02-27 | 108.88K shares 10-K · filed 2023-03-29 |
| 2022-09-30 | 111.73M shares 10-Q · filed 2023-11-14 | 107.07M shares derived: average of 2 quarters · filed 2023-11-14 | 105.46M shares 10-Q · filed 2023-11-14 | 6.20M shares derived: average of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | 102.41M shares 10-Q · filed 2023-08-14 | 102.27M shares 10-Q · filed 2023-08-14 | -28.98M shares derived: average of 3 quarters · filed 2023-08-14 | 3.74M shares derived: average of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | 102.12M shares 10-Q · filed 2023-05-11 | -94.68M shares derived: average of 2 quarters · filed 2023-05-11 | -29.15M shares derived: average of 3 quarters · filed 2023-05-11 | 2.75M shares derived: average of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -291.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -94.79M shares derived: average of 2 quarters · filed 2023-03-29 | -30.37M shares derived: average of 3 quarters · filed 2023-03-29 | 98.47K shares 10-K · filed 2023-03-29 | |
| 2021-09-30 | 101.91M shares 10-Q · filed 2022-11-08 | 100.18M shares derived: average of 2 quarters · filed 2022-11-08 | 97.29M shares 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | 98.46M shares 10-Q · filed 2022-08-09 | 94.94M shares 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |